Royal Bank of Canada
CABA icon

Royal Bank of Canada’s Cabaletta Bio CABA Stock Holding History

Royal Bank of Canada’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2K Buy
781
+658
+535% +$1.83K ﹤0.01% 6670
2025
Q4 		$0 Sell
123
-91,600
-100% -$227K ﹤0.01% 7189
2025
Q3 		$214K Buy
91,723
+91,660
+145,492% +$157K ﹤0.01% 5049
2025
Q2 		$0 Sell
63
-2,300
-97% -$3.59K ﹤0.01% 7043
2025
Q1 		$4K Sell
2,363
-62,379
-96% -$133K ﹤0.01% 6393
2024
Q4 		$147K Sell
64,742
-22,415
-26% -$78.7K ﹤0.01% 5073
2024
Q3 		$411K Buy
87,157
+20,095
+30% +$116K ﹤0.01% 4250
2024
Q2 		$501K Sell
67,062
-10,183
-13% -$125K ﹤0.01% 4010
2024
Q1 		$1.32M Sell
77,245
-19,711
-20% -$423K ﹤0.01% 3235
2023
Q4 		$2.2M Sell
96,956
-7,807
-7% -$131K ﹤0.01% 2994
2023
Q3 		$1.59M Sell
104,763
-11,042
-10% -$151K ﹤0.01% 3055
2023
Q2 		$1.5M Buy
115,805
+14,707
+15% +$160K ﹤0.01% 3061
2023
Q1 		$836K Buy
101,098
+100,854
+41,334% +$944K ﹤0.01% 3478
2022
Q4 		$2K Sell
244
-140
-36% -$510 ﹤0.01% 6916
2022
Q3 		$0 Buy
+384
New +$462 ﹤0.01% 7465
2021
Q3 		– Sell
-1,476
Closed -$13K – 7639
2021
Q2 		$13K Buy
1,476
+120
+9% +$1.18K ﹤0.01% 6764
2021
Q1 		$15K Buy
1,356
+665
+96% +$8.12K ﹤0.01% 6593
2020
Q4 		$9K Buy
+691
New +$8.96K ﹤0.01% 6411
2020
Q3 		– Sell
-10
Closed – – 6636
2020
Q2 		$0 Sell
10
-303
-97% -$2.32K ﹤0.01% 6636
2020
Q1 		$2K Sell
313
-90
-22% -$1.23K ﹤0.01% 6273
2019
Q4 		$6K Buy
+403
New +$4.78K ﹤0.01% 6288

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Royal Bank of Canada's CABA Position: Q1 2026 in Review

Royal Bank of Canada increased its Cabaletta Bio (CABA) stake by 535% in Q1 2026, buying an estimated $1.83K and bringing the position to 781 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #6670.

Royal Bank of Canada first reported a position in CABA in Q4 2019 and has held it in 21 quarters since. The position peaked at $2.2M in Q4 2023. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

  • Royal Bank of Canada held 781 shares of Cabaletta Bio worth $2K as of Q1 2026.
  • Royal Bank of Canada bought 658 Cabaletta Bio shares in Q1 2026, an estimated $1.83K.
  • Cabaletta Bio made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6670 holding.
  • Royal Bank of Canada first reported a position in Cabaletta Bio in Q4 2019 and has held it in 21 quarters since.
  • Royal Bank of Canada's Cabaletta Bio position peaked at $2.2M in Q4 2023.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.